ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,963.60
      0.59%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.245
      -0.20%
      Bitcoin
      57,235.40
      0.92%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Dyne Therapeutics Inc (DYN)

      7. Dyne Therapeutics Inc (DYN) News

      DYN

      Dyne Therapeutics (DYN)

      Dyne Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DYN
      DateTimeSourceHeadlineSymbolCompany
      01/19/20244:38PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:DYNDyne Therapeutics Inc
      01/19/20249:08AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DYNDyne Therapeutics Inc
      01/11/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      01/11/20244:05PMGlobeNewswire Inc.Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional SharesNASDAQ:DYNDyne Therapeutics Inc
      01/05/20244:07PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DYNDyne Therapeutics Inc
      01/05/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYNDyne Therapeutics Inc
      01/05/20247:30AMGlobeNewswire Inc.Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DYNDyne Therapeutics Inc
      01/04/202410:46PMGlobeNewswire Inc.Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common StockNASDAQ:DYNDyne Therapeutics Inc
      01/04/20249:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      01/04/20249:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      01/04/20249:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
      01/04/20249:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
      01/04/20249:19PMEdgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:DYNDyne Therapeutics Inc
      01/04/20245:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYNDyne Therapeutics Inc
      01/03/20248:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
      01/03/20248:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
      01/03/20244:37PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DYNDyne Therapeutics Inc
      01/03/20244:25PMGlobeNewswire Inc.Dyne Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:DYNDyne Therapeutics Inc
      01/03/20246:37AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYNDyne Therapeutics Inc
      01/03/20246:30AMGlobeNewswire Inc.Dyne Therapeutics Announces Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients Demonstrating Promise of the FORCE™ Platform in Developing Therapeutics for Rare Muscle DiseasesNASDAQ:DYNDyne Therapeutics Inc
      01/02/20244:05PMGlobeNewswire Inc.Dyne Therapeutics to Host Virtual Event Tomorrow, January 3 at 8:00 AM ET, to Present Initial Clinical Data from ACHIEVE and DELIVER TrialsNASDAQ:DYNDyne Therapeutics Inc
      12/29/20239:03PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYNDyne Therapeutics Inc
      12/12/20235:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      12/12/20235:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      12/12/20235:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      11/16/20234:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      11/16/20234:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      11/16/20234:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYNDyne Therapeutics Inc
      11/07/20237:30AMGlobeNewswire Inc.Dyne Therapeutics to Present at November Investor ConferencesNASDAQ:DYNDyne Therapeutics Inc
      10/30/20237:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYNDyne Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:DYN